Literature DB >> 2434311

Postsynaptic potentials in motoneurons caused by spinal cord stimulation in humans.

K Guru, A Mailis, P Ashby, G Vanderlinden.   

Abstract

Epidural spinal cord stimulation (SCS) causes facilitation and/or inhibition of spinal motoneurons many segments below the level of the cathode. On the assumption that a spinal cord pathway is activated by the cathode the conduction velocity of the fiber system responsible for the facilitation of soleus motoneurons was estimated to be between 21.5 and 27 m/sec. It is clear that SCS in man can generate postsynaptic potentials in spinal neurons and thus is capable of modifying transmission in spinal segmental pathways.

Entities:  

Mesh:

Year:  1987        PMID: 2434311     DOI: 10.1016/0013-4694(87)90076-9

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  4 in total

1.  Initiating extension of the lower limbs in subjects with complete spinal cord injury by epidural lumbar cord stimulation.

Authors:  B Jilge; K Minassian; F Rattay; M M Pinter; F Gerstenbrand; H Binder; M R Dimitrijevic
Journal:  Exp Brain Res       Date:  2003-10-25       Impact factor: 1.972

2.  Segmental effects of epidural spinal cord stimulation in humans.

Authors:  J P Hunter; P Ashby
Journal:  J Physiol       Date:  1994-02-01       Impact factor: 5.182

3.  Modulation of multisegmental monosynaptic responses in a variety of leg muscles during walking and running in humans.

Authors:  Grégoire Courtine; Susan J Harkema; Christine J Dy; Yuri P Gerasimenko; Poul Dyhre-Poulsen
Journal:  J Physiol       Date:  2007-04-19       Impact factor: 5.182

Review 4.  Recent update on basic mechanisms of spinal cord injury.

Authors:  Syed A Quadri; Mudassir Farooqui; Asad Ikram; Atif Zafar; Muhammad Adnan Khan; Sajid S Suriya; Chad F Claus; Brian Fiani; Mohammed Rahman; Anirudh Ramachandran; Ian I T Armstrong; Muhammad A Taqi; Martin M Mortazavi
Journal:  Neurosurg Rev       Date:  2018-07-11       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.